Zum Inhalt der Seite gehen
Here's the latest variant picture with a global scope.

The DeFLuQE variants remain dominant, but growth appears to have stalled.

Growth of XEC.* has continued, reaching 28%.

#COVID19 #Global #DeFLuQE #XEC
🧵

#COVID19 #global #defluqe #xec
Mike Honey
XEC.* variants show a steady growth advantage of 1.8% per day (13% per week) over the dominant DeFLuQE variants. That predicts a possible crossover in December.
🧵

⇧